ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,015Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 153

$532K Total Retail Price of All Prescriptions

Rank: 9 out of 153

325 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 325 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 325 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,133 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
LISINOPRIL 553 461 1 3
SERTRALINE HCL 510 485 2 16
LEVOTHYROXINE SODIUM 501 416 3 1
OMEPRAZOLE 494 374 4 4
MIRTAZAPINE 358 344 5 47
SIMVASTATIN 339 304 6 2
METOPROLOL TARTRATE 331 266 7 11
METFORMIN HCL 264 218 8 8
HYDROCODONE-ACETAMINOPHEN 216 180 S3 9 5
DONEPEZIL HCL 194 194 10 26
GABAPENTIN 188 170 11 15
ALENDRONATE SODIUM 183 153 12 22
NAMENDA 182 169 13 28
AMLODIPINE BESYLATE 179 153 14 7
FUROSEMIDE 169 145 15 6
WARFARIN SODIUM 158 116 16 10
LANTUS 147 124 17 44
ADVAIR DISKUS 143 131 18 31
TRAZODONE HCL 130 86 19 32
HYDROCHLOROTHIAZIDE 124 95 20 9
EXELON 113 100 21 116
SPIRIVA 112 107 22 35
POTASSIUM CHLORIDE 110 93 23 12
PRAVASTATIN SODIUM 99 86 24 20
TRAMADOL HCL 92 89 25 23
CYMBALTA 91 59 26 39
TAMSULOSIN HCL 88 86 27 24
ATORVASTATIN CALCIUM 84 61 28 19
VENLAFAXINE HCL ER 77 46 29 70
ESCITALOPRAM OXALATE 73 64 30 55
PREDNISONE 73 66 30 29
PANTOPRAZOLE SODIUM 73 73 30 30
BUSPIRONE HCL 71 71 33 71
CARBIDOPA-LEVODOPA 70 58 34 91
MORPHINE SULFATE ER 64 19 S2 35 52
METOPROLOL SUCCINATE 63 62 36 13
OLANZAPINE 63 50 36 85
LOSARTAN POTASSIUM 62 62 38 17
ATENOLOL 62 39 38 18
FENTANYL 61 37 S2 40 56
DIVALPROEX SODIUM 61 51 40 66
FLUOXETINE HCL 58 37 42 51
DIGOXIN 55 55 43 40
IPRATROPIUM-ALBUTEROL 53 53 44 110
CITALOPRAM HBR 52 41 45 14
ENALAPRIL MALEATE 52 40 45 42
ZOLPIDEM TARTRATE 51 32 47 21
LIDODERM 51 47 47 157
CARVEDILOL 51 39 47 36
FLUTICASONE PROPIONATE 50 32 50 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.